Clinical Trial Update: Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer [NA]

View source ↗

Summary

A not-yet-recruiting clinical trial evaluating a liposomal irinotecan combination regimen as second-line therapy for advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Liposomal irinotecan (liposomal irinotecan)

Snippet

Sponsor: Hunan Cancer Hospital | Conditions: Advanced Gastric Cancer | NA | Status: NOT_YET_RECRUITING